NFATc1/αA: The other Face of NFAT Factors in Lymphocytes

Abstract

In effector T and B cells immune receptor signals induce within minutes a rise of intracellular Ca++, the activation of the phosphatase calcineurin and the translocation of NFAT transcription factors from cytosol to nucleus. In addition to this first wave of NFAT activation, in a second step the occurrence of NFATc1/αA, a short isoform of NFATc1, is strongly induced. Upon primary stimulation of lymphocytes the induction of NFATc1/αA takes place during the G1 phase of cell cycle. Due to an auto-regulatory feedback circuit high levels of NFATc1/αA are kept constant during persistent immune receptor stimulation. Contrary to NFATc2 and further NFATc proteins which dampen lymphocyte proliferation, induce anergy and enhance activation induced cell death (AICD), NFATc1/αA supports antigen-mediated proliferation and protects lymphocytes against rapid AICD. Whereas high concentrations of NFATc1/αA can also lead to apoptosis, in collaboration with NF-κB-inducing co-stimulatory signals they support the survival of mature lymphocytes in late phases after their activation. However, if dysregulated, NFATc1/αA appears to contribute to lymphoma genesis and – as we assume – to further disorders of the lymphoid system. While the molecular details of NFATc1/αA action and its contribution to lymphoid disorders have to be investigated, NFATc1/αA differs in its generation and function markedly from all the other NFAT proteins which are expressed in lymphoid cells. Therefore, it represents a prime target for causal therapies of immune disorders in future.

Selective NFAT targeting in T cells ameliorates GvHD while maintaining antitumor activity

“…Thus, NFAT2-in particular the short isoform NFAT2/ αA directed by the Nfat2 P1 promoter-is directly involved in T-cell activation, proliferation, and expression of proinflammatory cytokines (12,26). However, in vitro Nfat1 −/− T cells show elevated proliferation, hyperactivation, and a bias toward a Th2 immune response (9).…”

Nuclear factor of activated T-cells (NFATC) as a possible diagnostic and prognostic marker in congenital valvular diseases and myocardial hypertrophy

“…Завдяки контролю Са-кальмодулін-залежною протеїн-фосфатазою (кальціневрином) щонайменше 5 NFATC протеїнів можна вважати чинни-ками транскрипції з дещо різними властивостями [12]. Уперше ці фактори (NFATc1-NFATc4) ідентифіковані в лімфоцитах як нуклеарний комплекс, що приєднується до промотера інтерлейкіну-2 та відіграє ключову роль в індуцибельній експресїї генів активованих Т-клітин.…”

Orai1-NFAT Signalling Pathway Triggered by T Cell Receptor Stimulation

“…The level of active nuclear NFAT depends both on the intensity of Ca 2+ influx and on the inducible kinases that are active under a particular stimulation condition. TCR stimulation also induces expression of a short isoform of NFAT2 (NFATc1), NFATc1/αA (Serfling et al, 2012). NFATc1/αA plays a more positive role in T cell activation than the other NFAT family members by supporting proliferation and protecting against cell death upon stimulation.…”